D89.4
Mast cell activation syndrome and related disorders
Clinical Classification Guidelines
Excludes Type 1
- aggressive systemic mastocytosis (C96.21)
- congenital cutaneous mastocytosis (Q82.2)
- (non-congenital) cutaneous mastocytosis (D47.01)
- (indolent) systemic mastocytosis (D47.02)
- malignant mast cell neoplasm (C96.2-)
- malignant mastocytoma (C96.29)
- mast cell leukemia (C94.3-)
- mast cell sarcoma (C96.22)
- mastocytoma NOS (D47.09)
- other mast cell neoplasms of uncertain behavior (D47.09)
- systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
Medical Intelligence & Overview
Mast Cell Activation Syndrome (MCAS), classified under ICD-10 code D89.4, is a condition characterized by the abnormal activation and release of chemical mediators from mast cells. Mast cells are a type of immune cell found throughout the body, especially in the skin, lungs, and digestive tract. In MCAS, these cells overreact to triggers, leading to a range of allergic and inflammatory symptoms. Although not a widely recognized condition initially, increased awareness has highlighted its role in various complex symptoms that mimic allergic reactions. Understanding the causes, symptoms, and possible management strategies can help individuals affected by this disorder to navigate their health more effectively.
Causes & Symptoms
Clinical Causes: Genetic predisposition influencing mast cell behavior Unknown precise trigger, but factors like infections and environmental exposures may activate mast cells Certain medications or foods that provoke mast cell responses Other underlying immune system abnormalities or disorders Chronic stress or hormonal changes that may influence immune responses
Key Symptoms: Hives or skin itching Swelling of face, lips, or throat Flushing or sudden redness of the skin Difficulty breathing or wheezing Gastrointestinal symptoms like nausea, diarrhea, or abdominal pain Headaches or migraines Light sensitivity and fatigue Rapid heartbeat or palpitations Low blood pressure episodes Anaphylactic reactions in severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing MCAS involves a thorough clinical evaluation of symptoms and their triggers. Physicians may perform blood tests to detect elevated levels of mast cell mediators such as tryptase, histamine, or prostaglandins during symptomatic periods. In some cases, urine tests measuring metabolites like N-methylhistamine provide additional insight. Since these markers can fluctuate, multiple tests may be necessary for confirmation. A detailed medical history and symptom diary also support diagnosis, along with ruling out other allergic or immune conditions.
Treatment Protocols: Use of antihistamines to block histamine effects, such as H1 and H2 receptor antagonists Mast cell stabilizers like cromolyn sodium to prevent cell activation Leukotriene receptor antagonists to reduce inflammatory mediators Avoidance of known triggers, including certain foods, medications, or environmental factors Lifestyle modifications like stress reduction techniques In some cases, epinephrine auto-injectors to manage severe reactions
Clinical Advice & FAQs
Billing Guidance
Is D89.4 a billable ICD-10 code?
Yes, D89.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.4?
Clinical documentation must specify the nature of Mast cell activation syndrome and related disorders and any associated comorbidities for accurate reporting.
Cite this Clinical Reference